Workday
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 3 in the most recent period (2026/Q4).
- Total institutional ownership (as a % of shares) was little changed.
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 82.12% -0.01pp
- Institutions
- 1,268 -3
- As of
- 2026/Q4 vs. prior period
Holder types
Top holders as of 2026-10-09
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 7 buys · 43 sells
| Name | Role | Stake |
|---|---|---|
| David Duffield | Co-Founder & CEO Emeritus | 14.77% |
| Aneel Bhusri | Co-Founder, CEO & Executive Chairman of the Board | 3.57% |
| Carl Eschenbach | Former Chief Executive Officer | 0.14% |
| George Still | Independent Director | 0.05% |
| Chih-Yuan Yang | Independent Director | 0.04% |
| Douglas Robinson | Former Co-President | 0.04% |
| Zane Rowe | Chief Financial Officer | 0.03% |
| Thomas Bogan | Independent Director | 0.02% |
| Richard Sauer | Chief Legal Officer, Head of Corporate Affairs & Corporate Secretary | 0.02% |
| Michael McNamara | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-11 | Mark Garfield | Chief Accounting Officer | Open Market Disposition | -918 | $189.45 |
| 2026-10-08 | David Duffield | Co-Founder & CEO Emeritus | Other Disposition | -99,835 | -- |
| 2026-10-08 | David Duffield | Co-Founder & CEO Emeritus | Derivative Exercise and Sale | -99,835 | $186.36–190.96 |
| 2026-10-05 | David Duffield | Co-Founder & CEO Emeritus | Derivative Exercise and Sale | -99,228 | $184.80–189.39 |
| 2026-10-05 | Zane Rowe | Chief Financial Officer | Automatic Disposition | -6,000 | $184.99–189.25 |
| 2026-10-05 | Gerrit Kazmaier | President of Product & Technology | Automatic Disposition | -2,729 | $184.85–189.49 |
| 2026-10-04 | Aneel Bhusri | Co-Founder, CEO & Executive Chairman of the Board | Sale to Issuer | -8,502 | $186.14 |
| 2026-10-04 | Zane Rowe | Chief Financial Officer | Sale to Issuer | -10,010 | $186.14 |
| 2026-10-04 | Robert Enslin | President & Chief Commercial Officer | Sale to Issuer | -5,634 | $186.14 |
| 2026-10-04 | Robert Enslin | President & Chief Commercial Officer | Automatic Disposition | -5,374 | $185.58–188.81 |
| 2026-10-04 | Robert Enslin | President & Chief Commercial Officer | Intent to Sell (Form 144) | -5,374 | $186.00 |
| 2026-10-04 | Mark Garfield | Chief Accounting Officer | Sale to Issuer | -3,491 | $186.14 |
| 2026-10-04 | Richard Sauer | Chief Legal Officer, Head of Corporate Affairs & Corporate Secretary | Sale to Issuer | -6,783 | $186.14 |
| 2026-10-04 | Gerrit Kazmaier | President of Product & Technology | Sale to Issuer | -8,976 | $186.14 |
| 2026-09-30 | David Duffield | Co-Founder & CEO Emeritus | Derivative Exercise and Sale | -98,446 | $183.86–194.77 |
| 2026-09-27 | David Duffield | Co-Founder & CEO Emeritus | Derivative Exercise and Sale | -98,971 | $182.67–190.60 |
| 2026-09-22 | David Duffield | Co-Founder & CEO Emeritus | Derivative Exercise and Sale | -99,613 | $188.92–193.62 |
| 2026-09-17 | David Duffield | Co-Founder & CEO Emeritus | Other Disposition | -94,089 | -- |
| 2026-09-17 | David Duffield | Co-Founder & CEO Emeritus | Derivative Exercise and Sale | -94,089 | $194.04–195.73 |
| 2026-09-14 | David Duffield | Co-Founder & CEO Emeritus | Derivative Exercise and Sale | -96,545 | $190.71–194.39 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.
Workday discussion 0 comments